Paper36927328
Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children.
Zhang Y and 7 others. BMC Pediatr, 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children. Papers, record 36927328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927328
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vascular Endothelial Growth Factor A | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Humans | |
| Child | |
| Glucuronidase | |
| Glycated Hemoglobin | |
| Vascular Endothelial Growth Factors | |
| Fibroblast Growth Factors |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31312972 | Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms. | Inflammation | 2019 | https://conductscience.org/library/papers/31312972 | PubMed |
| 2 | 2188676 | Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. | Annu Rev Immunol | 1990 | https://conductscience.org/library/papers/2188676 | PubMed |
| 3 | 34603200 | Soluble Klotho Is Decreased in Children With Type 1 Diabetes and Correlated With Metabolic Control. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34603200 | PubMed |
| 4 | 35008398 | Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35008398 | PubMed |
| 5 | 28620823 | The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes. | Diabetologia | 2017 | https://conductscience.org/library/papers/28620823 | PubMed |
| 6 | 18609104 | Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test. | Scand J Clin Lab Invest | 2008 | https://conductscience.org/library/papers/18609104 | PubMed |
| 7 | 27069929 | Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio. | J Diabetes Res | 2016 | https://conductscience.org/library/papers/27069929 | PubMed |
| 8 | 11956156 | Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. | Endocrinology | 2002 | https://conductscience.org/library/papers/11956156 | PubMed |
| 9 | 32546231 | Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters. | BMC Pediatr | 2020 | https://conductscience.org/library/papers/32546231 | PubMed |
| 10 | 21653700 | Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21653700 | PubMed |
| 11 | 31632345 | Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31632345 | PubMed |
| 12 | 20017932 | Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). | BMC Pediatr | 2009 | https://conductscience.org/library/papers/20017932 | PubMed |
| 13 | 15840014 | Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? | Kidney Int | 2005 | https://conductscience.org/library/papers/15840014 | PubMed |
| 14 | 31849842 | The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31849842 | PubMed |
| 15 | 30852757 | Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner. | J Endocrinol Invest | 2019 | https://conductscience.org/library/papers/30852757 | PubMed |
| 16 | 28544968 | Clinical usefulness of videocapillaroscopy and selected endothelial cell activation markers in people with Type 1 diabetes mellitus complicated by microangiopathy. | Adv Med Sci | 2017 | https://conductscience.org/library/papers/28544968 | PubMed |
| 17 | 28993191 | The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28993191 | PubMed |
| 18 | 34320286 | Long-Term Complications in Youth-Onset Type 2 Diabetes. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34320286 | PubMed |
| 19 | 31614355 | Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21. | Kidney Blood Press Res | 2019 | https://conductscience.org/library/papers/31614355 | PubMed |
| 20 | 33842597 | Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33842597 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42078327 | Investigating salivary growth factor responses to tooth extraction in patients with type 2 diabetes: a prospective observational comparative study. | Front Oral Health | 2026 | https://conductscience.org/library/papers/42078327 |
Source PubMed
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36927328
GET https://conductscience.org/api/papers/v1/36927328/references?page=2